2 major healthcare players come together over AI expansion

GE and Boston’s Partners Healthcare are combining their considerable forces to inject AI deeper into healthcare, and they’re starting with—what else?—radiology.

“Without disclosing specifics, both companies said they will spend a significant amount on the initiative. And both stand to gain revenue if they’re successful in creating useful software programs that can be sold to hospitals around the globe,” the Boston Globe reports.

“There’s hundreds if not thousands of applications throughout medicine,” says Keith Dreyer, DO, PhD, chief data science officer in the radiology departments of Partners’ founding hospitals, Massachusetts General and Brigham & Women’s.

The newspaper says the GE-Partners partnership is the biggest AI project to date.

“GE and Partners said they will develop an open platform that eventually can house hundreds of applications to help interpret medical data,” the Globe reports. “They’re starting with radiology because that field, dealing with digital pictures from MRI and CT machines, more easily lends itself to computer analysis.”

Read the whole thing:  

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.